Rho-kinase: important new therapeutic target in cardiovascular diseases

K Satoh, Y Fukumoto… - American Journal of …, 2011 - journals.physiology.org
Rho-kinase (ROCKs) belongs to the family of serine/threonine kinases and is an important
downstream effector of the small GTP-binding protein RhoA. There are two isoforms of Rho …

Rho kinases in cardiovascular physiology and pathophysiology: the effect of fasudil

J Shi, L Wei - Journal of cardiovascular pharmacology, 2013 - journals.lww.com
Rho kinase (ROCK) is a major downstream effector of the small GTPase RhoA. ROCK
family, consisting of ROCK1 and ROCK2, plays central roles in the organization of actin …

Rho kinases in cardiovascular physiology and pathophysiology

G Loirand, P Guérin, P Pacaud - Circulation research, 2006 - Am Heart Assoc
Rho kinases (ROCKs) are the first and the best-characterized effectors of the small G-protein
RhoA. In addition to their effect on actin organization, or through this effect, ROCKs have …

Targeting ROCK signaling in health, malignant and non-malignant diseases

R Shahbazi, B Baradaran, M Khordadmehr, S Safaei… - Immunology letters, 2020 - Elsevier
A Rho-associated coiled-coil kinase (ROCK) is identified as a critical downstream effector of
GTPase RhoA which contains two isoforms, ROCK1 (also known as p160ROCK and ROKβ) …

Rho kinase inhibitors: a patent review (2014–2016)

O Defert, S Boland - Expert opinion on therapeutic patents, 2017 - Taylor & Francis
ABSTRACT Introduction: The Rho-kinases (ROCK), ROCK1 and ROCK2, are potent,
widespread biochemical modulators which have been extensively studied. Due to the …

Potent, selective and orally bioavailable dihydropyrimidine inhibitors of Rho kinase (ROCK1) as potential therapeutic agents for cardiovascular diseases

CA Sehon, GZ Wang, AQ Viet… - Journal of medicinal …, 2008 - ACS Publications
Recent studies using known Rho-associated kinase isoform 1 (ROCK1) inhibitors along with
cellular and molecular biology data have revealed a pivotal role of this enzyme in many …

Rho-associated coiled-coil-forming kinases (ROCKs): potential targets for the treatment of atherosclerosis and vascular disease

Q Zhou, C Gensch, JK Liao - Trends in pharmacological sciences, 2011 - cell.com
ROCKs are important regulators of the actin cytoskeleton. Because changes in the actin
cytoskeleton underlie vascular contractility and remodeling, inflammatory cell recruitment …

[HTML][HTML] Striking crosstalk of ROCK signaling with endothelial function

K Noma, Y Kihara, Y Higashi - Journal of cardiology, 2012 - Elsevier
Rho-associated coiled-coil forming protein kinases (ROCKs), the downstream target
proteins of RhoA, are ubiquitously expressed serine-threonine protein kinases. ROCKs have …

[HTML][HTML] Rho-associated coiled-coil kinase (ROCK) in molecular regulation of angiogenesis

J Liu, Y Wada, M Katsura, H Tozawa, N Erwin… - Theranostics, 2018 - ncbi.nlm.nih.gov
Identified as a major downstream effector of the small GTPase RhoA, Rho-associated coiled-
coil kinase (ROCK) is a versatile regulator of multiple cellular processes. Angiogenesis, the …

ROCK (RhoA/Rho kinase) in cardiovascular–renal pathophysiology: a review of new advancements

TM Seccia, M Rigato, V Ravarotto, LA Calò - Journal of Clinical Medicine, 2020 - mdpi.com
Rho-associated, coiled-coil containing kinases (ROCK) were originally identified as effectors
of the RhoA small GTPase and found to belong to the AGC family of serine/threonine …